Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1342.5% | -958.0% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 3.6 | 3.0 |
Pr/Book | 0.4 |
Latest | F'cast | |
---|---|---|
Revenue | 31.5% | 23.4% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-19 | 0.05 | (17.23) | (44.11)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-20 | 6.07 | (13.86) | (34.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 0.26 | (13.41) | (29.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 0.40 | (11.06) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | 0.53 | (6.66) | (9.50)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-24 | 0.65 | (6.26) | (9.14)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-25 | 12.11 | 4.84 | 7.18p | 0.5 | n/a | n/a | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Appointment of Administrators | 20-Mar-2024 | 15:43 | RNS |
Intention to Appoint Administrators | 20-Mar-2024 | 12:30 | RNS |
Block Listing Review & Total Voting Rights | 01-Mar-2024 | 07:00 | RNS |
Reneuron tests stem cell stroke treatment | 03-Sep-2014 | The Herald |
ReNeuron unveils board shake-up as chairman move... | 21-Jul-2011 | The Scotsman |
ReNeuron shares in healthy shape | 04-Mar-2011 | The Scotsman |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 3.38p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 11.13 |
52 Week Low | 3.38 |
Volume | 0 |
Shares Issued | 57.17m |
Market Cap | £1.93m |
RiskGrade | 394 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research